Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddy's laboratories australia pty ltd - irbesartan -

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - omeprazole 10mg;   - modified release capsule - 10 mg - active: omeprazole 10mg   excipient: capsugel purple op.c046 capsugel yellow op.c305 crospovidone hypromellose isopropyl alcohol magnesium stearate mannitol meglumine methacrylic acid - ethyl acrylate copolymer opacode black s-1-27794 poloxamer povidone purified water triethyl citrate

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg - film coated tablet - 100 mg - active: sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry white oy-58900 polysorbate 80 sodium starch glycolate - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg - film coated tablet - 50 mg - active: sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry white oy-58900 polysorbate 80 sodium starch glycolate - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ferrous fumarate 310mg;  ; folic acid 0.35mg;   - film coated tablet - 310mg/0.35mg - active: ferrous fumarate 310mg   folic acid 0.35mg   excipient: glycerol hypromellose iron oxide red macrogol 400 macrogol 6000 magnesium stearate microcrystalline cellulose povidone purified talc sodium laurilsulfate sodium starch glycolate titanium dioxide - for the prevention and treatment of iron and folic acid deficiency anaemia, including during pregnancy.

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - budesonide - gastro-resistant granules - 9 milligram(s) - corticosteroids acting locally; budesonide

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - ursodeoxycholic acid - oral suspension - 250 mg/5ml - bile acid preparations; ursodeoxycholic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - ursodeoxycholic acid - capsule, hard - 250 milligram(s) - bile acid preparations; ursodeoxycholic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

dr. falk pharma gmbh - ursodeoxycholic acid - film-coated tablet - 500 milligram(s) - bile acid preparations; ursodeoxycholic acid

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - bosentan monohydrate 129.082mg equivalent to bosentan 125 mg - film coated tablet - 125 mg - active: bosentan monohydrate 129.082mg equivalent to bosentan 125 mg excipient: ethylcellulose glycerol magnesium stearate maize starch opadry yellow 03k82318 povidone sodium starch glycolate starch - the medicine is indicated for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, pulmonary arterial hypertension associated with scleroderma or pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who class iii or iv symptoms.